ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 111 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $1,072 | -46.3% | 15,162 | 0.0% | 0.00% | – |
Q3 2023 | $1,998 | -74.2% | 15,162 | 0.0% | 0.00% | – |
Q2 2023 | $7,733 | -19.0% | 15,162 | 0.0% | 0.00% | – |
Q1 2023 | $9,552 | -41.5% | 15,162 | -39.7% | 0.00% | – |
Q4 2022 | $16,333 | -62.0% | 25,162 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $43,000 | +38.7% | 25,162 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $31,000 | +93.8% | 25,162 | 0.0% | 0.00% | – |
Q1 2022 | $16,000 | -40.7% | 25,162 | 0.0% | 0.00% | – |
Q4 2021 | $27,000 | -41.3% | 25,162 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $46,000 | -13.2% | 25,162 | +24.8% | 0.00% | 0.0% |
Q2 2021 | $53,000 | -27.4% | 20,162 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $73,000 | -73.4% | 20,162 | -81.4% | 0.00% | -80.0% |
Q3 2020 | $274,000 | +80.3% | 108,681 | +134.3% | 0.01% | +66.7% |
Q2 2020 | $152,000 | +33.3% | 46,378 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $114,000 | -42.4% | 46,378 | +10.8% | 0.00% | -25.0% |
Q4 2019 | $198,000 | +44.5% | 41,866 | +30.7% | 0.00% | +33.3% |
Q3 2019 | $137,000 | -29.7% | 32,028 | -4.0% | 0.00% | -25.0% |
Q2 2019 | $195,000 | +51.2% | 33,378 | 0.0% | 0.00% | +33.3% |
Q1 2019 | $129,000 | +118.6% | 33,378 | +6.4% | 0.00% | +50.0% |
Q4 2018 | $59,000 | -41.0% | 31,378 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $100,000 | -58.8% | 31,378 | -19.8% | 0.00% | -75.0% |
Q2 2017 | $243,000 | -2.0% | 39,108 | 0.0% | 0.01% | -11.1% |
Q1 2017 | $248,000 | +18.7% | 39,108 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $209,000 | -5.0% | 39,108 | 0.0% | 0.01% | -10.0% |
Q3 2016 | $220,000 | +2.3% | 39,108 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $215,000 | -33.6% | 39,108 | -10.3% | 0.01% | -37.5% |
Q1 2016 | $324,000 | -2.7% | 43,608 | +8.7% | 0.02% | -5.9% |
Q4 2015 | $333,000 | -5.4% | 40,108 | +2.6% | 0.02% | -5.6% |
Q3 2015 | $352,000 | -42.0% | 39,108 | -22.7% | 0.02% | -35.7% |
Q2 2015 | $607,000 | +61.0% | 50,616 | +44.6% | 0.03% | +64.7% |
Q1 2015 | $377,000 | -32.4% | 35,000 | -68.2% | 0.02% | -34.6% |
Q4 2014 | $558,000 | +606.3% | 110,000 | +266.7% | 0.03% | +550.0% |
Q3 2014 | $79,000 | – | 30,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 15,151,516 | $49,697,000 | 12.67% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 9,642,760 | $31,628,000 | 5.74% |
MILLER VALUE PARTNERS, LLC | 12,619,730 | $41,393,000 | 1.84% |
MAGNOLIA CAPITAL ADVISORS LLC | 90,585 | $297,000 | 0.38% |
Sargent Investment Group, LLC | 232,025 | $759,000 | 0.28% |
Old West Investment Management, LLC | 210,583 | $690,000 | 0.20% |
Virtus ETF Advisers LLC | 112,619 | $369,000 | 0.18% |
tru Independence LLC | 213,712 | $701,000 | 0.10% |
AIGEN INVESTMENT MANAGEMENT, LP | 180,297 | $591,000 | 0.08% |
Golden State Wealth Management, LLC | 90,585 | $297,000 | 0.08% |